BIOMAT Database Logo BIOMAT Database Logo

Real prevalence of pulmonary right-to-left shunt according to genotype in patients with hereditary hemorrhagic telangiectasia: a transthoracic contrast echocardiography study. 2010

Marco W F van Gent, and Martijn C Post, and Repke J Snijder, and Cornelis J J Westermann, and Herbert W M Plokker, and Johannes J Mager
Department of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands.

BACKGROUND Transthoracic contrast echocardiography (TTCE) can detect pulmonary right-to-left shunting (RLS) and is used to screen for pulmonary arteriovenous malformations (PAVMs) in patients with hereditary hemorrhagic telangiectasia (HHT). We studied the prevalence and size of pulmonary RLS in HHT type 1, HHT type 2, and HHT-negative controls, and its positive predictive value (PPV) and negative predictive value (NPV) for PAVMs that can be treated by embolotherapy. METHODS In 343 consecutive persons referred for possible HHT as first-degree family members of index patients a TTCE and chest CT scan were performed. All persons were offered genetic analysis. RESULTS An HHT-causing mutation was confirmed in 92 (mean age 41 ± 15 y; 59% female) HHT1 relatives and in 97 (mean age 47 ± 14 y; 52% female) HHT2 relatives. TTCE showed a pulmonary RLS in 78 (85%) HHT1- and 34 (35%) HHT2-related mutation carriers, respectively (P < .0001). In HHT1 relatives, 29 of 53 (55%) PAVMs and in HHT2 relatives three of 17 (18%) PAVMS were treated, resulting in a PPV of TTCE for treatable PAVMs of 36.3% and 8.3%, respectively. The accompanying NPV was 100%. A minimal, moderate, or large shunt was present in 12 (13%), 24 (26%), and 42 (46%) HHT1-related, and in 20 (21%), 6 (6%), and 8 (8%) HHT2-related mutation carriers, respectively (P for trend < .0001). A large shunt predicted treatable PAVMs in 55.8% of HHT1 relatives and 37.5% of HHT2 relatives. TTCE was positive in four (6%) of 63 persons without HHT. CONCLUSIONS A pulmonary shunt on TTCE is more prevalent and larger in HHT1- compared with HHT2-related mutation carriers. Shunt grading is helpful to predict treatable PAVMs, particularly in the HHT2 group. TTCE is also positive in a small fraction of persons without HHT.

UI MeSH Term Description Entries
D008297 Male Males
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001165 Arteriovenous Malformations Abnormal formation of blood vessels that shunt arterial blood directly into veins without passing through the CAPILLARIES. They usually are crooked, dilated, and with thick vessel walls. A common type is the congenital arteriovenous fistula. The lack of blood flow and oxygen in the capillaries can lead to tissue damage in the affected areas. Arteriovenous Malformation,Malformation, Arteriovenous,Malformations, Arteriovenous
D013683 Telangiectasia, Hereditary Hemorrhagic An autosomal dominant vascular anomaly characterized by telangiectases of the skin and mucous membranes and by recurrent gastrointestinal bleeding. This disorder is caused by mutations of a gene (on chromosome 9q3) which encodes endoglin, a membrane glycoprotein that binds TRANSFORMING GROWTH FACTOR BETA. Osler-Rendu Disease,Rendu-Osler-Weber Disease,Weber-Osler Disease,Weber-Osler Syndrome,Hereditary Hemorrhagic Telangiectasia,Osler's Disease,Osler-Rendu-Weber Disease,Osler-Weber-Rendu Syndrome,Telangiectasia, Hereditary Hemorrhagic, Type 1,Telangiectasia, Hereditary Hemorrhagic, of Rendu, Osler, and Weber,Hemorrhagic Telangiectasia, Hereditary,Osler Disease,Osler Rendu Disease,Osler Rendu Weber Disease,Osler Weber Rendu Syndrome,Rendu Osler Weber Disease,Weber Osler Disease,Weber Osler Syndrome

Related Publications

Marco W F van Gent, and Martijn C Post, and Repke J Snijder, and Cornelis J J Westermann, and Herbert W M Plokker, and Johannes J Mager
Reproducibility of right-to-left shunt quantification using transthoracic contrast echocardiography in hereditary haemorrhagic telangiectasia.
April 2018, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation,
Marco W F van Gent, and Martijn C Post, and Repke J Snijder, and Cornelis J J Westermann, and Herbert W M Plokker, and Johannes J Mager
[Detection of right-to-left shunt with transthoracic contrast echocardiography in patients with pulmonary hypertension].
June 2020, Zhonghua yi xue za zhi,
Marco W F van Gent, and Martijn C Post, and Repke J Snijder, and Cornelis J J Westermann, and Herbert W M Plokker, and Johannes J Mager
A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine.
October 2005, Chest,
Marco W F van Gent, and Martijn C Post, and Repke J Snijder, and Cornelis J J Westermann, and Herbert W M Plokker, and Johannes J Mager
Contrast-enhanced transthoracic echocardiography applied in evaluation of pulmonary right-to-left shunt: A preliminary study.
September 2018, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society,
Marco W F van Gent, and Martijn C Post, and Repke J Snijder, and Cornelis J J Westermann, and Herbert W M Plokker, and Johannes J Mager
Interventional embolization of a giant pulmonary arteriovenous malformation with right-left-shunt associated with hereditary hemorrhagic telangiectasia.
March 2006, Clinical research in cardiology : official journal of the German Cardiac Society,
Marco W F van Gent, and Martijn C Post, and Repke J Snijder, and Cornelis J J Westermann, and Herbert W M Plokker, and Johannes J Mager
Follow-up of pulmonary right-to-left shunt in hereditary haemorrhagic telangiectasia.
June 2016, The European respiratory journal,
Marco W F van Gent, and Martijn C Post, and Repke J Snijder, and Cornelis J J Westermann, and Herbert W M Plokker, and Johannes J Mager
Screening for right-to-left shunts with contrast transcranial Doppler in hereditary hemorrhagic telangiectasia.
May 2011, Stroke,
Marco W F van Gent, and Martijn C Post, and Repke J Snijder, and Cornelis J J Westermann, and Herbert W M Plokker, and Johannes J Mager
Role of contrast echocardiography in screening for pulmonary arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia.
October 2010, Chest,
Marco W F van Gent, and Martijn C Post, and Repke J Snijder, and Cornelis J J Westermann, and Herbert W M Plokker, and Johannes J Mager
High prevalence of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
April 2013, European journal of internal medicine,
Marco W F van Gent, and Martijn C Post, and Repke J Snijder, and Cornelis J J Westermann, and Herbert W M Plokker, and Johannes J Mager
Which technique is better for detection of right-to-left shunt in patients with patent foramen ovale: comparing contrast transthoracic echocardiography with contrast transesophageal echocardiography.
October 2014, Echocardiography (Mount Kisco, N.Y.),
Copied contents to your clipboard!